{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:53:21Z","timestamp":1792108401681,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T00:00:00Z","timestamp":1633824000000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ejca.2020.09.011","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T07:09:28Z","timestamp":1602313768000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Mesothelioma in children and adolescents: the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) contribution"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-139X","authenticated-orcid":false,"given":"Daniel","family":"Orbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines B.","family":"Brecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"L\u00f3pez Almaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Ben-Ami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Vermersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Carton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3651-9416","authenticated-orcid":false,"given":"Calogero","family":"Virgone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Bisogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik T.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viera","family":"Bajciova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Reguerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Galateau-Salle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Stachowicz-Stencel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Dvir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Bien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Ben Arush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejca.2020.09.011_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.21037\/tlcr.2018.08.03","article-title":"Update on the management of malignant peritoneal mesothelioma","volume":"7","author":"Sugarbaker","year":"2018","journal-title":"Transl Lung Cancer Res"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.011_bib2","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2019-0024","article-title":"Multicystic peritoneal mesothelioma: a systematic review of the literature","volume":"4","author":"Noiret","year":"2019","journal-title":"Pleura Peritoneum"},{"issue":"10026","key":"10.1016\/j.ejca.2020.09.011_bib3","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.011_bib4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/oem.2005.023200","article-title":"The French national mesothelioma surveillance program","volume":"63","author":"Goldberg","year":"2006","journal-title":"Occup Environ Med"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.011_bib5","first-page":"659","article-title":"Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives","volume":"31","author":"Boussios","year":"2018","journal-title":"Ann Gastroenterol"},{"issue":"5","key":"10.1016\/j.ejca.2020.09.011_bib6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl428","article-title":"A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma","volume":"18","author":"Yan","year":"2007","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.011_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/030089160509100101","article-title":"Malignant peritoneal mesothelioma","volume":"91","author":"de Pangher Manzini","year":"2005","journal-title":"Tumori"},{"issue":"14","key":"10.1016\/j.ejca.2020.09.011_bib8","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2020.09.011_bib9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/1097-0142(19880815)62:4<838::AID-CNCR2820620433>3.0.CO;2-9","article-title":"Mesothelioma of childhood","volume":"62","author":"Fraire","year":"1988","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2020.09.011_bib10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1309\/AJCPHV33LJTVDGJJ","article-title":"Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy","volume":"130","author":"Arrossi","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.011_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/pbc.21718","article-title":"Treatment of peritoneal mesothelioma in pediatric patients","volume":"52","author":"Cioffredi","year":"2009","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.ejca.2020.09.011_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/1097-0142(196404)17:4<539::AID-CNCR2820170416>3.0.CO;2-A","article-title":"Mesothelioma in children","volume":"17","author":"Kauffman","year":"1964","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2020.09.011_bib13","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1183\/09031936.96.09091932","article-title":"The epidemiology of mesothelioma in historical context","volume":"9","author":"McDonald","year":"1996","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ejca.2020.09.011_bib14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1684\/bdc.2010.1064","article-title":"[Paediatric mesothelioma: is there the such a disease?]","volume":"97","author":"Kashanskiy","year":"2010","journal-title":"Bull Cancer"},{"key":"10.1016\/j.ejca.2020.09.011_bib15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejca.2018.12.031","article-title":"Defining and listing very rare cancers of paediatric age: consensus of the joint action on rare cancers in cooperation with the European cooperative study group for pediatric rare tumors","volume":"110","author":"Ferrari","year":"2019","journal-title":"Eur J Canc"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.011_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/era.12.155","article-title":"The founding of the European cooperative study group on pediatric rare tumors--EXPeRT","volume":"13","author":"Ferrari","year":"2013","journal-title":"Expert Rev Anticancer Ther"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.011_bib17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-0032-1327608","article-title":"Rare cancers in children - the EXPeRT initiative: a report from the European cooperative study group on pediatric rare tumors","volume":"224","author":"Bisogno","year":"2012","journal-title":"Klin P\u00e4diatr"},{"issue":"8","key":"10.1016\/j.ejca.2020.09.011_bib18","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jtho.2018.04.023","article-title":"New insights on diagnostic reproducibility of biphasic mesotheliomas: a multi-institutional evaluation by the international mesothelioma panel from the MESOPATH reference center","volume":"13","author":"Galateau Salle","year":"2018","journal-title":"J Thorac Oncol"},{"issue":"9483","key":"10.1016\/j.ejca.2020.09.011_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.011_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/030089160308900307","article-title":"Clinical presentation of peritoneal mesothelioma","volume":"89","author":"Acherman","year":"2003","journal-title":"Tumori"},{"issue":"12","key":"10.1016\/j.ejca.2020.09.011_bib21","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/oemed-2018-105108","article-title":"Are children more vulnerable to mesothelioma than adults? A comparison of mesothelioma risk among children and adults exposed non-occupationally to blue asbestos at Wittenoom","volume":"75","author":"Reid","year":"2018","journal-title":"Occup Environ Med. Dec"},{"issue":"2","key":"10.1016\/j.ejca.2020.09.011_bib22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/ajcp\/86.2.227","article-title":"Pleural malignant mesothelioma following Wilms' tumor","volume":"86","author":"Austin","year":"1986","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.011_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.mrrev.2007.08.001","article-title":"Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor","volume":"658","author":"Ugolini","year":"2008","journal-title":"Mutat Res"},{"issue":"10","key":"10.1016\/j.ejca.2020.09.011_bib24","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.011_bib25","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/JTO.0b013e31817c73d6","article-title":"Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaive patients with malignant pleural mesothelioma: results of the International Expanded Access Program","volume":"3","author":"Santoro","year":"2008","journal-title":"J Thorac Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2020.09.011_bib26","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/01.cad.0000236312.50833.a7","article-title":"Efficacy of a combination of pemetrexed and multiple redo-surgery in an 11-year-old girl with a recurrent multifocal abdominal mesothelioma","volume":"17","author":"Milano","year":"2006","journal-title":"Anti Canc Drugs"},{"issue":"12","key":"10.1016\/j.ejca.2020.09.011_bib27","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2006.09.1694","article-title":"Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group","volume":"25","author":"Malempati","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2020.09.011_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/pbc.24244","article-title":"Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group study","volume":"60","author":"Warwick","year":"2013","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.ejca.2020.09.011_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejca.2019.10.034","article-title":"Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review","volume":"127","author":"Auer","year":"2020","journal-title":"Eur J Canc"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.011_bib30","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.jpedsurg.2017.09.014","article-title":"Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for disseminated intra-abdominal malignancies in children-a single-institution experience","volume":"53","author":"Zmora","year":"2018","journal-title":"J Pediatr Surg"},{"issue":"4","key":"10.1016\/j.ejca.2020.09.011_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26934","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal perfusion with chemotherapy in children with peritoneal tumor spread: a French nationwide study over 14 years","volume":"65","author":"Scalabre","year":"2018","journal-title":"Pediatr Blood Canc"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.011_bib32","doi-asserted-by":"crossref","first-page":"e28286","DOI":"10.1002\/pbc.28286","article-title":"Multicystic and diffuse malignant peritoneal mesothelioma in children","volume":"67","author":"Vermersch","year":"2020","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.ejca.2020.09.011_bib33","series-title":"Cancer","author":"Myers","year":"2019"},{"issue":"2","key":"10.1016\/j.ejca.2020.09.011_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpag.2015.10.018","article-title":"Pediatric benign cystic peritoneal mesothelioma","volume":"29","author":"Durell","year":"2015","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.011_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0032-1308987","article-title":"Malignant peritoneal mesothelioma in a 16-year-old girl: presentation of a rare disease","volume":"224","author":"Brecht","year":"2012","journal-title":"Klin P\u00e4diatr"},{"key":"10.1016\/j.ejca.2020.09.011_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.19.00048","article-title":"STRN-ALK rearranged malignant peritoneal mesothelioma with dramatic response following ceritinib treatment","volume":"3","author":"R\u00fcschoff","year":"2019","journal-title":"JCO Precision Oncology"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.011_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jtho.2019.11.011","article-title":"Anaplastic lymphoma Kinase gene rearrangement in children and young adults with mesothelioma","volume":"15","author":"Mian","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"29","key":"10.1016\/j.ejca.2020.09.011_bib38","doi-asserted-by":"crossref","first-page":"20781","DOI":"10.18632\/oncotarget.25111","article-title":"A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy","volume":"9","author":"Monch","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2020.09.011_bib39","first-page":"e28666","article-title":"Precision medicine at its best: Prolonged survival in a child presenting a secondary mesothelioma treated with crizotinib","author":"Petit","year":"2020","journal-title":"Pediatr Blood Canc"},{"issue":"12","key":"10.1016\/j.ejca.2020.09.011_bib40","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Canc Discov"},{"issue":"Suppl 1","key":"10.1016\/j.ejca.2020.09.011_bib41","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.21037\/tlcr.2019.11.23","article-title":"Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives","volume":"9","author":"Gray","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ejca.2020.09.011_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fonc.2020.00187","article-title":"Immunotherapy in malignant pleural mesothelioma","volume":"10","author":"de Gooijer","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.011_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(19)30671-0","article-title":"Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial","volume":"21","author":"Geoerger","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920304949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920304949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:29:30Z","timestamp":1760732970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804920304949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":43,"alternative-id":["S0959804920304949"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.09.011","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesothelioma in children and adolescents: the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) contribution","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}